Mary Gray
Director/Board Member chez KEROS THERAPEUTICS, INC.
Fortune : 128 678 $ au 31/03/2024
Profil
Mary Ann Gray is the founder and president of Gray Strategic Advisors LLC, which was founded in 2003.
She is currently serving as an independent director at BioAtla, Inc., Rapt Therapeutics, Inc., Keros Therapeutics, Inc., and Compass Therapeutics, Inc. Dr. Gray has previously held positions as an independent director at Catalent JNP, Inc., Sarepta Therapeutics, Inc., Dyax Corp., Telik, Inc., ACADIA Pharmaceuticals, Inc., TetraLogic Pharmaceuticals Corp., and Galena Biopharma, Inc. She has also served as a director at Seneca Biopharma, Inc., Apthera, Inc., and rEVO Biologics, Inc. Additionally, Dr. Gray has held roles as a senior scientist at Poniard Pharmaceuticals, Inc. and Schering-Plough Corp., as well as a principal at Raymond James & Associates, Inc. and Burrill LLC.
She was a portfolio manager at Federated Hermes Kaufmann Fund from 1999 to 2003 and a fund manager at Federated Investment Management Co. from 1999 to 2003.
Dr. Gray obtained her undergraduate degree from the University of South Carolina in 1973 and her doctorate degree from the University of Vermont in 1985.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOATLA, INC.
0,08% | 31/12/2023 | 37 397 ( 0,08% ) | 128 646 $ | 31/03/2024 |
PALISADE BIO, INC.
0,00% | 15/03/2024 | 80 ( 0,00% ) | 32 $ | 31/03/2024 |
RAPT THERAPEUTICS, INC.
-.--% | 28/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
| 09/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 | |
KEROS THERAPEUTICS, INC.
-.--% | 06/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Mary Gray
| Sociétés | Poste | Début |
|---|---|---|
| SENOMYX INC. | Director/Board Member | 28/09/2010 |
| RAPT THERAPEUTICS, INC. | Director/Board Member | 04/12/2019 |
| BIOATLA, INC. | Director/Board Member | 01/12/2020 |
| KEROS THERAPEUTICS, INC. | Director/Board Member | 17/12/2020 |
| COMPASS THERAPEUTICS, INC. | Director/Board Member | 25/04/2022 |
| Gray Strategic Advisors LLC | Founder | 01/08/2003 |
Anciens postes connus de Mary Gray
| Sociétés | Poste | Fin |
|---|---|---|
| PALISADE BIO, INC. | Director/Board Member | 04/03/2024 |
| SAREPTA THERAPEUTICS, INC. | Director/Board Member | 02/06/2022 |
| JUNIPER PHARMACEUTICALS INC | Director/Board Member | 01/08/2018 |
| ░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Mary Gray
| University of South Carolina | Undergraduate Degree |
| University of Vermont | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 9 |
|---|---|
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
| BIOATLA, INC. | Health Technology |
| RAPT THERAPEUTICS, INC. | Health Technology |
| KEROS THERAPEUTICS, INC. | Health Technology |
| COMPASS THERAPEUTICS, INC. | Health Technology |
| PALISADE BIO, INC. | Health Technology |
| Entreprise privées | 16 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Pharmaceuticals: MajorHealth Technology Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets. The company was founded in December 1986 and is headquartered in Somerset, NJ. | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Raymond James & Associates, Inc.
 Raymond James & Associates, Inc. Financial ConglomeratesFinance Raymond James & Associates, Inc. (RJA) is a registered broker-dealer headquartered in St. Petersburg, Florida. The firm was founded in 1962 and is a subsidiary of Raymond James Financial, Inc. (NYSE: RJF), a diversified holding company. RJA offers a full array of capital markets services, strategic advice and planning for institutional investors. | Finance |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Health Technology |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Finance |
| Federated Hermes Kaufmann Fund | Miscellaneous |
| Kidder Peabody | Finance |
Federated Investment Management Co.
 Federated Investment Management Co. Investment ManagersFinance Federated Investment Management Co. (FIMCO) is a mutual fund manager and SEC-registered investment advisor headquartered in Pittsburgh, Pennsylvania. The firm is a subsidiary of FII Holdings, Inc. and their ultimate parent is Federated Investors, Inc. (NYSE: FII). FIMCO offers domestic and international equity, fixed-income and money market mutual funds, as well as a variety of separate account options for a wide range of investors. | Finance |
| Warburg Dillon Read LLC | Finance |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. | Health Technology |
Apthera, Inc.
 Apthera, Inc. Medical/Nursing ServicesHealth Services Apthera, Inc. develops a pipeline of peptide-based immunotherapies for cancers. It has products in clinical trials aimed at reducing disease recurrence rates for breast, prostate, and pancreatic cancers. The company was founded Robert E. Kennedy, William Gannon, and Joseph Sinkule in July, 2005 and is headquartered in Scottsdale, AZ. | Health Services |
| Gray Strategic Advisors LLC | |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
